http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08dd3bd6530476e10af82b7a3e96af8
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Nick |
| name | Alpa M Nick Alpa M. Nick |
| given-name | Alpa M Alpa M. |
| organization-name | Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Authors' Affiliations: 1University of Texas M.D. Anderson Cancer Center, Houston, Texas; 2Vanderbilt University Medical Center, Nashville, Tennessee; 3IDDI Corp., Houston, Texas; 4University of Texas Medical Branch at Galveston, Galveston, Texas; 5Moffitt Cancer Center, Tampa, Florida; 6University of Arkansas for Medical Sciences, Little Rock, Arkansas; 7St. Luke's Roosevelt Hospital Center, New York, New York; and 8University of Iowa, Iowa City, Iowa The University of Texas MD Anderson Cancer Center, Houston, TX Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, and 3Experimental Therapeutics; 4Center for RNA Interference and Non-Coding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 5Department of Pathology and 6Medicine, University of Southern California; and 7Vasgene Therapeutics, Los Angeles, California Authors' Affiliations: 1Department of Gynecologic Oncology, 2Department of Cancer Biology, and 3Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 4Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 5Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; 6Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine; 7Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, South Korea; 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, South Korea; and 10Medimmune, LLC, Gaithersburg, Maryland Authors' Affiliation: Departments of 1Gynecologic Oncology,2Genitourinary Medical Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Noncoding RNA, The University of Texas M.D. Anderson Cancer Center; and 6Department of Radiation Biophysics, University of Space Research Association, NASA Johnson Space Center, Houston, Texas; 7Department of Obstetrics and Gynecology, Division of Gynecologic Oncology and UW Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine; 9Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 10Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; and 11Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Korea; and 12Department of Obstetrics & Gynec Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, 3Pathology, and 4Experimental Therapeutics, 5Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Center for Reproductive Sciences, University of California, San Francisco, California 1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Gynecologic Oncology and 2Cancer Biology, and 3Center for RNAi and Non-Coding RNA, M.D. Anderson Cancer Center, and 4Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Baylor College of Medicine, Houston, Texas; and 5Cancer Research, GlaxoSmithKline, Collegeville, Pennsylvania Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; and Departments of 2Gynecologic Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, U.T.M.D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1Division of Cancer Medicine, Departments of 2Gynecologic Oncology, 3Gastrointestinal Medical Oncology, 4Pathology, 5Surgical Oncology, 6Cancer Biology, 7Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 8Biocept Inc., San Diego, California; and 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, Korea Department of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston Texas Authors' Affiliations: 1Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston; Departments of 2Gynecologic Oncology, 3Cancer Biology, 4Experimental Therapeutics, and 5Surgical Oncology, and 6Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 7Department of Bioengineering, Rice University; and 8Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 9Department of Biomedical Engineering, University of Texas Austin, Austin, Texas; and 10Department of Surgery and 11The University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico Authors' Affiliations: 1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PR China; Departments of 2Experimental Diagnostic Imaging, 3Diagnostic Radiology, 4Gynecologic Oncology, and 5Cancer Biology, 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PR China; Departments of 2Experimental Diagnostic Imaging, 3Diagnostic Radiology, 4Gynecologic Oncology, and 5Cancer Biology, 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Bioinformatics and Computational Biology, 2Gynecologic Oncology and Reproductive Medicine, 3Experimental Therapeutics, 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Fred Hutchinson Cancer Research Center, Seattle, Washington 1Gynecologic Oncology, Departments of Authors' Affiliations: Departments of 1Experimental Therapeutics, 2Gynecologic Oncology, 3Systems Biology, 4Cancer Biology, and 5Center for RNAi and non-coding-RNA, University of Texas M. D. Anderson Cancer Center; and 6Department of Bioengineering and Division of Applied Physics, Rice University, Houston, Texas; 7University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, Puerto Rico; 8Centro de Investigación y de Estudios Avanzados del IPN, Unidad Monterrey, PIIT, Apodaca NL, Mexico; and 9Division of Gynecologic Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Systems Biology, 3Pathology, 4Experimental Therapeutics, 5Bioinformatics and Computational Biology, 6Cancer Biology, 7Thoracic/Head and Neck Medical Oncology, and 8The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; 1Gynecologic Oncology and Departments of Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Surgical Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-coding RNA, The University of Texas M.D. Anderson Cancer Center, and 6Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 7Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, 9Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, and 10Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Korea; 11Department of Surgery, School of Medicine, University of Puerto Rico, and 12University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico; and 13Department of Obstetrics & Gynecology, Dongguk University IIsan Hospital, Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; 2Department of Gynecologic Oncology, U.T.M.D. Anderson Cancer Center, Houston, Texas; 3Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 4Department of Experimental Therapeutics, U.T.M.D. Anderson Cancer Center, Houston, Texas; 5The University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, PR; and 6Center for RNA Interference and Non-Coding RNA; 7Department of Cancer Biology, U.T.M.D. Anderson Cancer Center, Houston, Texas Departments of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX |
Incoming Links
Showing number of triples: 1 to 133 of 133.